Format

Send to

Choose Destination
J Am Coll Cardiol. 2014 Sep 30;64(13):1388-400. doi: 10.1016/j.jacc.2014.04.083.

Metabolic impairment in heart failure: the myocardial and systemic perspective.

Author information

1
Centre for Stroke Research Berlin and Department of Cardiology, Campus Virchow-Klinikum Charité-Universitätsmedizin Berlin, Berlin, Germany. Electronic address: wolfram.doehner@charite.de.
2
University of Aberdeen School of Medicine and Dentistry, Aberdeen, United Kingdom.
3
Department of Innovative Clinical Trials, University Medical Centre, Göttingen, Germany.

Abstract

Although bioenergetic starvation is not a new concept in heart failure (HF), recent research has led to a growing appreciation of the complexity of metabolic aspects of HF pathophysiology. All steps of energy extraction, transfer, and utilization are affected, and structural metabolism is impaired, leading to compromised functional integrity of tissues. Not only the myocardium, but also peripheral tissues and organs are affected by metabolic failure, resulting in a global imbalance between catabolic and anabolic signals, leading to tissue wasting and, ultimately, to cachexia. Metabolic feedback signals from muscle and fat actively contribute to further myocardial strain, promoting disease progression. The prolonged survival of patients with stable, compensated HF will increasingly bring chronic metabolic complications of HF to the fore and gradually shift its clinical presentation. This paper reviews recent evidence on myocardial and systemic metabolic impairment in HF and summarizes current and emerging therapeutic concepts with specific metabolic targets.

KEYWORDS:

cachexia; insulin resistance; metabolism; muscle; sarcopenia; stroke

PMID:
25257642
DOI:
10.1016/j.jacc.2014.04.083
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center